VISCERAL LEISHMANIASIS IN THE BALB C MOUSE - A COMPARISON OF THE IN-VIVO ACTIVITY OF 5 NONIONIC SURFACTANT VESICLE PREPARATIONS OF SODIUM STIBOGLUCONATE/
Dm. Williams et al., VISCERAL LEISHMANIASIS IN THE BALB C MOUSE - A COMPARISON OF THE IN-VIVO ACTIVITY OF 5 NONIONIC SURFACTANT VESICLE PREPARATIONS OF SODIUM STIBOGLUCONATE/, Journal of drug targeting., 3(1), 1995, pp. 1-7
Five non-ionic surfactants (Surfactants V - IX) were screened for thei
r ability to produce vesicles for the delivery of sodium stibogluconat
e. Mean vesicle diameter and antimony content were determined prior to
in vivo assessment of antiparasitic activity in a mouse model of acut
e visceral leishmaniasis. V/D suspensions (i.e. stibogluconate loaded
vesicles kept in the hydrating drug solution) were more effective agai
nst spleen, liver and bone marrow parasites than drug loaded vesicle s
uspensions that had unentrapped drug removed. A Surfactant IX V/D susp
ension was the most active antileishmanial preparation causing 74 +/-
10%, 99 +/- 1% and 38 +/- 8% suppression of liver, spleen and bone mar
row parasite burdens respectively. Contrary to previous findings, a re
duction in splenic and bone marrow parasite burdens was achieved using
large vesicles (mean diameter > 800nm). The significance of these res
ults is discussed.